Exact Sciences Corporation
EXAS
$46.35
$0.461.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.37% | 11.91% | 13.54% | 15.21% | 19.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.37% | 11.91% | 13.54% | 15.21% | 19.93% |
| Cost of Revenue | 13.91% | 28.86% | 28.69% | 25.86% | 28.41% |
| Gross Profit | 8.88% | 5.90% | 8.08% | 11.25% | 16.71% |
| SG&A Expenses | 2.79% | -1.13% | -0.78% | 0.40% | -1.57% |
| Depreciation & Amortization | -- | -97.59% | -99.17% | -99.60% | -100.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.54% | 4.14% | 5.28% | 4.40% | 2.64% |
| Operating Income | 37.96% | 49.22% | 41.99% | 42.89% | 55.39% |
| Income Before Tax | -413.60% | 25.14% | 60.37% | 54.48% | 68.11% |
| Income Tax Expenses | -403.95% | 317.21% | 214.76% | 147.33% | 126.51% |
| Earnings from Continuing Operations | -403.97% | 24.13% | 59.46% | 53.51% | 67.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -403.97% | 24.13% | 59.46% | 53.51% | 67.26% |
| EBIT | 37.96% | 49.22% | 41.99% | 42.89% | 55.39% |
| EBITDA | 161.09% | 125.60% | 90.37% | 74.77% | 83.38% |
| EPS Basic | -390.03% | 25.81% | 60.38% | 54.59% | 67.92% |
| Normalized Basic EPS | 39.32% | 58.03% | 48.47% | 47.66% | 58.12% |
| EPS Diluted | -390.95% | 25.62% | 60.37% | 54.58% | 67.94% |
| Normalized Diluted EPS | 38.99% | 57.86% | 48.82% | 47.94% | 58.34% |
| Average Basic Shares Outstanding | 2.25% | 2.17% | 2.11% | 2.09% | 2.15% |
| Average Diluted Shares Outstanding | 1.77% | 1.68% | 2.59% | 2.57% | 2.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
